Figure 5From: Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer Analysis of survival by risk category in recurrent cases. The zero timepoint indicates the diagnosis of recurrence. (A) Survival according to CDK1SA-based risk with a cut-off value of 12.6 maU/eU. (B) Survival according to CDK2SA-based risk with a cut-off value of 222 maU/eU.Back to article page